AIDS

1. OMLAND LH, Senn A, Zutavern A, Orban M, et al
   Disability pension and sick leave in people with HIV compared with the background population - a nationwide population-based matched cohort study.
   AIDS. 2025 Dec 10. doi: 10.1097/QAD.0000000000004422.
   

   >> Share

   
   
2. DE BEER ST, Phelanyane F, Ingle SM, Slogrove AL, et al
   Infectious-cause hospitalisation in a province-wide cohort of children with antenatal HIV exposure compared to children without HIV exposure.
   AIDS. 2025 Dec 10. doi: 10.1097/QAD.0000000000004423.
   

   >> Share

   
   

   
   Am J Epidemiol

3. RUDOLPH JE, Zhou Y, Palatino M, Yenokyan K, et al
   Sampling for computational efficiency when conducting analyses in big data.
   Am J Epidemiol. 2025 Dec 5:kwaf268. doi: 10.1093.
   

   >> Share

   
   

   
   BMC Immunol

4. ZHENG J, Zhang C, Zhang L, Wang X, et al
   Mp1p antigen as a sensitive diagnostic marker for early detection and treatment monitoring of Talaromyces Marneffei infection.
   BMC Immunol. 2025;26:98.
   

   >> Share

   
   
5. ZHANG J, Ni J, Kong W, Liu J, et al
   Variable clinical features and delayed diagnosis in six Chinese patients with anti-interferon-gamma autoantibodies: a retrospective analysis in a university hospital in China.
   BMC Immunol. 2025 Dec 8. doi: 10.1186/s12865-025-00786.
   

   >> Share

   
   

   
   BMC Pediatr

6. KUTEESA NP, Isoke R, Abeja CJ
   Prevalence and factors associated with sero-conversion among HIV exposed infants receiving care at Lira regional referral hospital in Lira City: a cross-sectional study.
   BMC Pediatr. 2025 Dec 13. doi: 10.1186/s12887-025-06191.
   

   >> Share

   
   

   
   Clin Infect Dis

7. MENDLOWITZ AB, Flemming JA, Kushner T, Wong WWL, et al
   Gaps in the Hepatitis C Prenatal and Postpartum Care Cascade: Rationale for Treatment in Pregnancy.
   Clin Infect Dis. 2025 Dec 9:ciaf578. doi: 10.1093.
   

   >> Share

   
   
8. MURPHY K, Gromisch M, Connolly J, Wang T, et al
   Impact of vaginal estradiol on the genitourinary syndrome of menopause, vaginal microbiome and mucosal immune mediators in women living with HIV.
   Clin Infect Dis. 2025 Dec 8:ciaf669. doi: 10.1093.
   

   >> Share

   
   

   
   HIV Med

9. LE NT, Ta ND, Vu TT, Tran KX, et al
   Assessing cancer-related mortality risk among people with HIV in Vietnam: A nationwide population study.
   HIV Med. 2025 Dec 6. doi: 10.1111/hiv.70161.
   

   >> Share

   
   
10. SATAPATHY P, Mehta R, Sah R
    Comment on "Dual cross-sectional and longitudinal perspective on the continuum of HIV care to disentangle natural epidemic evolution from real progress, Belgium 2014-2022".
    HIV Med. 2025 Dec 7. doi: 10.1111/hiv.70116.
    

    >> Share

    
    
11. VAN BECKHOVEN D, Serrien B, Demeester R, Van Praet J, et al
    Reply to Satapathy et al.'s comment on "Dual cross-sectional and longitudinal perspective on the continuum of HIV care to disentangle natural epidemic evolution from real progress, Belgium 2014-2022".
    HIV Med. 2025 Dec 7. doi: 10.1111/hiv.70163.
    

    >> Share

    
    
12. COSMARO ML, Penon S, Falzetta F, Candela C, et al
    TelePrEP in Italy: A remote service to expand equitable access to HIV pre-exposure prophylaxis.
    HIV Med. 2025 Dec 8. doi: 10.1111/hiv.70179.
    

    >> Share

    
    
13. NOORMAN MAJ, de Wit JBF, Marcos TA, Stutterheim SE, et al
    Towards inclusive HIV cure development: Identifying important and acceptable HIV cure attributes and strategies among people with HIV in the Netherlands.
    HIV Med. 2025 Dec 10. doi: 10.1111/hiv.70165.
    

    >> Share

    
    
14. GARTLAND M, Wang X, Liao Q, Li B, et al
    Exploring the impact of baseline and on-treatment variables on durability of responses to fostemsavir through weeks 96 and 192 in the phase 3 BRIGHTE study.
    HIV Med. 2025 Dec 12. doi: 10.1111/hiv.70154.
    

    >> Share

    
    
15. CURTO C, Tritzali M, Bamford A, Bailey AC, et al
    Late diagnosis of paediatric HIV infection in high-income countries: Lessons from the HIV Perinatal Virtual Clinic.
    HIV Med. 2025 Dec 12. doi: 10.1111/hiv.70164.
    

    >> Share

    
    

    
    J Acquir Immune Defic Syndr

16. DOSHI S, Richardson BA, Nazzinda R, Mugerwa H, et al
    The Association of Mild Kidney Disease With Coronary Artery Disease Is Stronger for People Living With HIV.
    J Acquir Immune Defic Syndr. 2026;101:95-102.
    

    >> Share

    
    
17. STARKS TJ, Hillesheim JR, Castiblanco J, Robles G, et al
    Adapted motivational interviewing reduces substance use and sexual risk taking among partnered sexual minority men aged 18 to 35: Results of the PARTNER study.
    J Acquir Immune Defic Syndr. 2025 Dec 4. doi: 10.1097/QAI.0000000000003813.
    

    >> Share

    
    
18. PARISI CE, Chichetto N, Li Z, Kwara A, et al
    Examining Survival of People Diagnosed with HIV in Florida Between 2015-2021 Following a Late, Delayed, or Timely Diagnosis.
    J Acquir Immune Defic Syndr. 2025 Dec 10. doi: 10.1097/QAI.0000000000003819.
    

    >> Share

    
    
19. SCHNARRS PW, Nash P, Ruderman SA, Crane HM, et al
    The Impact of Childhood Household Violence on HIV-Related Outcomes in People With HIV in the United States: The Role of Psychological Distress and Social Stressors.
    J Acquir Immune Defic Syndr. 2026;101:60-68.
    

    >> Share

    
    
20. AVOUNDJIAN T, Robertson MM, Abdelqader F, Braunstein SL, et al
    Impact of a Revised Ryan White Part A HIV Care Coordination Program on Viral Suppression and Durable Viral Suppression.
    J Acquir Immune Defic Syndr. 2026;101:77-85.
    

    >> Share

    
    

    
    J Am Acad Dermatol

21. HOMBAL A, McPhillips R, Hubbard L, Vincent N, et al
    Evaluating the Efficacy of Treatment Options for Cutaneous HIV-Related Kaposi Sarcoma: A Systematic Review & Meta-Analysis.
    J Am Acad Dermatol. 2025 Dec 8:S0190-9622(25)03351.
    

    >> Share

    
    

    
    J Clin Invest

22. ABELMAN RA, Schnittman SR, Faraj Murad N, Olshen A, et al
    Age modifies the association between sex and the plasma inflammatory proteome in treated HIV.
    J Clin Invest. 2025 Dec 9:e196869. doi: 10.1172/JCI196869.
    

    >> Share

    
    

    
    J Infect Dis

23. BASTING CM, Klatt NR
    Dissecting the Impact of the Gut Microbiome on HIV Reservoir Dynamics.
    J Infect Dis. 2025 Dec 9:jiaf560. doi: 10.1093.
    

    >> Share

    
    
24. GIANELLA S
    The Day I Was Told I Wasn't Doing Science-And Why I'm Grateful for It.
    J Infect Dis. 2025 Dec 5:jiaf614. doi: 10.1093.
    

    >> Share

    
    
25. BUCHBINDER SP, Anderson PL
    On-Demand Dosing of HIV Preexposure Prophylaxis for Women: Has Their Time Finally Come?
    J Infect Dis. 2025 Dec 9:jiaf507. doi: 10.1093.
    

    >> Share

    
    

    
    J Med Virol

26. LI Q, Cao Y, Yu Y, Zhang Y, et al
    Cervical/Anal HPV-Cytology Concordance With Colposcopic-Anoscopic Pathology: 984 Women Without HIV in China's Largest Lower Genital Tract Center.
    J Med Virol. 2025;97:e70710.
    

    >> Share

    
    

    
    J Virol

27. DIAZ-SALINAS MA, Benlarbi M, Chatterjee D, Nayrac M, et al
    Conformational dynamics of the HIV-1 envelope glycoprotein from CRF01_AE is associated with susceptibility to antibody-dependent cellular cytotoxicity.
    J Virol. 2025 Dec 9:e0166725. doi: 10.1128/jvi.01667.
    

    >> Share

    
    

    
    Lancet Infect Dis

28. BEHRENS GMN, Assoumou L, Liegeon G, Antinori A, et al
    Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial.
    Lancet Infect Dis. 2025 Dec 1:S1473-3099(25)00681.
    

    >> Share

    
    
29. HEATH PT, Zuma-Gwala N, Helmig RB, Horne E, et al
    Immunogenicity and safety of a group B Streptococcus vaccine (GBS-AlpN) in pregnant women and their infants: a phase 2, multicentre, observer-blind, randomised, placebo-controlled study.
    Lancet Infect Dis. 2025 Dec 9:S1473-3099(25)00659.
    

    >> Share

    
    

    
    Pediatr Infect Dis J

30. TORRE P 3RD, Sirag E, Williams PL, Zhang Z, et al
    Hearing Measures in Children Perinatally HIV-exposed and Uninfected in the PHACS SMARTT Study.
    Pediatr Infect Dis J. 2025 Dec 8. doi: 10.1097/INF.0000000000005098.
    

    >> Share

    
    

    
    PLoS Med

31. MCLAUGHLIN A, Toy J, Montoya V, Sereda P, et al
    Heterogeneous impacts of HIV pre-exposure prophylaxis (PrEP) on drug resistance and phylogenetic cluster transmission dynamics in British Columbia, Canada: A retrospective cohort and simulation study.
    PLoS Med. 2025;22:e1004827.
    

    >> Share

    
    

    
    PLoS One

32. PALMER S, Dijkstra M, Kigoro A, Mohamed K, et al
    "They recognize me as a doctor": A peer mobilisation training programme to promote oral HIV self-testing and referral for acute HIV infection screening among gay and bisexual men and transgender women in coastal Kenya, an exploratory study.
    PLoS One. 2025;20:e0322255.
    

    >> Share

    
    
33. KATEETE DP, Namakula S, Kigozi E, Katabazi FA, et al
    Patterns of compensatory mutations in rpoA/B/C genes of multidrug resistant M. tuberculosis in Uganda.
    PLoS One. 2025;20:e0328957.
    

    >> Share

    
    
34. OWIDI E, Ngure K, Mogere P, Njoroge J, et al
    Mental health service delivery among adolescent girls and young women (AGYW) seeking HIV prevention and treatment services in central Kenya: A qualitative study of AGYW and healthcare providers' perceptions.
    PLoS One. 2025;20:e0337795.
    

    >> Share

    
    
35. MSONGELA M, Musiba G, Mohamed JA, Marealle AI, et al
    In-hospital survival of adults with HIV-associated cryptococcal meningitis in Tanzania: A retrospective comparison of amphotericin B-based regimen and fluconazole monotherapy.
    PLoS One. 2025;20:e0332786.
    

    >> Share

    
    
36. TOMA TM, Sapo AA, Wada HW, Andarige KT, et al
    Proportion of depression and associated factors among HIV-positive youth attending antiretroviral therapy clinics at public hospitals in Gamo and Ari zones, South Ethiopia: A facility-based cross-sectional study.
    PLoS One. 2025;20:e0337588.
    

    >> Share

    
    
37. BERNER-RODOREDA A, Chione B, Ngwira E, Dambe R, et al
    Stakeholder communication and client understanding of viral load suppression in Blantyre, Malawi-What role did U = U play before the flip the script campaign?
    PLoS One. 2025;20:e0334337.
    

    >> Share

    
    
38. GETAHUN M, Kebede Y, Molalegn H, Alemu A, et al
    Contribution of xpert MTB/RIF assay and Urine LF-LAM for the diagnosis of tuberculosis in children aged 5 - 14 years, at selected health facilities in Ethiopia, 2016 - 2019.
    PLoS One. 2025;20:e0338557.
    

    >> Share

    
    
39. SU TT, Bayoumi AM, Avery L, Carusone SC, et al
    Trajectories of disability and influence of contextual factors among adults aging with HIV: Insights from a community-based longitudinal study in Toronto, Canada.
    PLoS One. 2025;20:e0309575.
    

    >> Share

    
    
40. MENGISTIE BA, Aragaw GM, Anteneh TA, Wondie KY, et al
    Prevalence and determinants of precancerous cervical lesions among women screened for cervical cancer in Africa: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0338484.
    

    >> Share

    
    
41. UDOH EE, Musa AZ, Olowolafe TA, Jaiyeola TM, et al
    Psychometric performance of the WHOQOL-HIV BREF among people living with HIV on antiretroviral therapy in Bauchi State, Nigeria.
    PLoS One. 2025;20:e0338095.
    

    >> Share

    
    
42. STANDL F, Senger L, Stich H
    Prevalence of sexually transmitted infections and immunization status among registered sex workers: A pilot study in lower Bavaria, Germany.
    PLoS One. 2025;20:e0338710.
    

    >> Share

    
    
43. MONENE LS, Tsima BM, Matlhagela K, Molefi M, et al
    An interrupted time series analysis of the effect of the quality improvement team on the rate of adverse events in the Botswana safe male circumcision program from 2015 to 2019.
    PLoS One. 2025;20:e0335587.
    

    >> Share

    
    

    
    PLoS Pathog

44. CORNISH D, Jackson-Jones KA, Ling-Hu T, Simons LM, et al
    Alternative polyadenylation upon CPSF6 knock-out enhances HIV-1 infection in primary T cells.
    PLoS Pathog. 2025;21:e1013745.
    

    >> Share

    
    
45. CANNAC M, Zoladek J, Bribes I, Fresneau-Resende M, et al
    SAMD9L inhibits flavivirus translation independently of its capacity to trigger innate immune response.
    PLoS Pathog. 2025;21:e1013773.
    

    >> Share

    
    

    
    Science

46. COHEN J
    'Functional cure' for HIV comes closer to reality.
    Science. 2025;390:970-971.
    

    >> Share

    
    

    
    Virology

47. CHANDANE-TAK M, Suneesh NS, Mukherjee S, Khan AA, et al
    Network-based integration of hsa-miR-150-5p reveals key regulatory roles in HIV-HCV coinfection and HCV-associated hepatocellular carcinoma.
    Virology. 2025;615:110747.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share